Quoin Pharmaceuticals (QNRX) Current Assets (2017 - 2026)

Quoin Pharmaceuticals has disclosed Current Assets across 10 years of filings, most recently posting $11.6 million for Q2 2026.

• In Q2 2026, Current Assets rose 37.23% year-over-year to $11.6 million; the TTM figure through Jun 2026 stood at $11.6 million (up 37.23% YoY), while the FY2025 annual figure was $20.0 million, up 34.04% from the prior year.
• Current Assets came in at $11.6 million for Q2 2026 at Quoin Pharmaceuticals, down from $15.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $20.0 million in Q4 2025 to a low of $3.5 million in Q2 2022.
• Average Current Assets over 5 years is $12.9 million, with a median of $13.4 million recorded in 2022.
• Year-over-year, Current Assets jumped 345.95% in 2023 and tumbled 42.7% in 2025.
• Over 5 years, Current Assets stood at $13.4 million in 2022, then slipped by 15.59% to $11.3 million in 2023, then surged by 32.25% to $14.9 million in 2024, then jumped by 34.04% to $20.0 million in 2025, then tumbled by 41.84% to $11.6 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $11.6 million in Q2 2026, $15.3 million in Q1 2026, and $20.0 million in Q4 2025.